Aryl hydrocarbon receptor control of a disease tolerance defence pathway

Nature

Volumn 511, Issue 7508, 2014, Pages 184-190

  Bessede, Alban ^a,b   Gargaro, Marco ^a   Pallotta, Maria T ^a   Matino, Davide ^a   Servillo, Giuseppe ^a   Brunacci, Cinzia ^a   Bicciato, Silvio ^c   Mazza, Emilia M C ^c   Macchiarulo, Antonio ^a   Vacca, Carmine ^a   Iannitti, Rossana ^a   Tissi, Luciana ^a   Volpi, Claudia ^a   Belladonna, Maria L ^a   Orabona, Ciriana ^a   Bianchi, Roberta ^a   Lanz, Tobias V ^d,e   Platten, Michael ^d,e   Della Fazia, Maria A ^a   Piobbico, Danilo ^a   Zelante, Teresa ^a   Funakoshi, Hiroshi ^f   Nakamura, Toshikazu ^g   Gilot, David ^h   Denison, Michael S ⁱ   Guillemin, Gilles J ^j   Duhadaway, James B ^k   Prendergast, George C ^k   Metz, Richard ^l   Geffard, Michel ^b   Boon, Louis ^m   Pirro, Matteo ^a   Iorio, Alfonso ⁿ   Veyret, Bernard ^b   Romani, Luigina ^a   Grohmann, Ursula ^a   Fallarino, Francesca ^a   Puccetti, Paolo ^a   more..

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f ASAHIKAWA MEDICAL COLLEGE   (Japan)

^g OSAKA UNIVERSITY   (Japan)

^h UNIVERSITÉ DE RENNES 1   (France)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j MACQUARIE UNIVERSITY   (Australia)

^k LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^l New Link Genetics Corporation   (United States)

^m BIOCEROS   (Netherlands)

ⁿ MCMASTER UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; ENDOTOXIN; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE 1; KYNURENINE; LIGAND; LIPOPOLYSACCHARIDE; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE; UNCLASSIFIED DRUG;

BACTERIAL DISEASE; DEFENSE BEHAVIOR; DISEASE CONTROL; DISEASE TREATMENT; ENZYME ACTIVITY; FITNESS; HYDROCARBON; IMMUNE SYSTEM; RODENT; SIGNALING; TOLERANCE; TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATABOLISM; CONTROLLED STUDY; DISEASE CONTROL; DOWN REGULATION; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HOST; IMMUNOPATHOLOGY; INFLAMMATION; MOUSE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BACTERIAL INFECTIONS; DISEASE RESISTANCE; ENDOTOXEMIA; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION; KYNURENINE; LIPOPOLYSACCHARIDES; MICE; PHOSPHORYLATION; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRYPTOPHAN OXYGENASE;

EID: 84904216760     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13323     Document Type: Article

References (48)

1. Fan, H. & Cook, J. A. Molecular mechanisms of endotoxin tolerance. J. Endotoxin Res. 10, 71-84 (2004).
2. Pena, O. M., Pistolic, J., Raj, D., Fjell, C. D. & Hancock, R. E. Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J. Immunol. 186, 7243-7254 (2011).
3. Krausgruber, T. et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nature Immunol. 12, 231-238 (2011).
4. Abdi, K., Singh, N. J. & Matzinger, P. Lipopolysaccharide-activated dendritic cells: ''exhausted'' or alert and waiting? J. Immunol. 188, 5981-5989 (2012).
5. Biswas, S. K. & Lopez-Collazo, E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475-487 (2009).
6. Park, S. H., Park-Min, K. H., Chen, J., Hu, X. & Ivashkiv, L. B. Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages. Nature Immunol. 12, 607-615 (2011).
7. Doreswamy, V. & Peden, D. B. Modulation of asthmaby endotoxin. Clin. Exp. Allergy 41, 9-19 (2011).
8. Stejskalova, L., Dvorak, Z. & Pavek, P. Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art. Curr. Drug Metab. 12, 198-212 (2011).
9. Quintana, F. J. The aryl hydrocarbon receptor: a molecular pathway for the environmental control of the immune response. Immunology 138, 183-189 (2013).
10. Kimura, A. et al. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J. Exp. Med. 206, 2027-2035 (2009).
11. Nguyen, L. P. & Bradfield, C. A. The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 21, 102-116 (2008).
12. Murray, M. F. The human indoleamine 2,3-dioxygenase gene and related human genes. Curr. Drug Metab. 8, 197-200 (2007).
13. Orabona, C. et al. Toward the identification of a tolerogenic signature in IDOcompetent dendritic cells. Blood 107, 2846-2854 (2006).
14. Stone, T. W., Stoy, N. & Darlington, L. G. An expanding range of targets for kynureninemetabolites of tryptophan. Trends Pharmacol. Sci. 34, 136-143 (2013).
15. Fallarino, F. et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor f-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 176, 6752-6761 (2006).
16. Nguyen, N. T. et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc. Natl Acad. Sci. USA 107, 19961-19966 (2010).
17. Mezrich, J. D. et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185, 3190-3198 (2010).
18. Romani, L. et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451, 211-215 (2008).
19. Changsirivathanathamrong, D. et al. Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis. Crit. Care Med. 39, 2678-2683 (2011).
20. Jung, I. D. et al. Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock. J. Immunol. 182, 3146-3154 (2009).
21. Sekine, H. et al. Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock. Mol. Cell. Biol. 29, 6391-6400 (2009).
22. Trifari, S., Kaplan, C. D., Tran, E. H., Crellin, N. K. & Spits, H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells. Nature Immunol. 10, 864-871 (2009).
23. Howard, G. J., Schlezinger, J. J., Hahn, M. E. & Webster, T. F. Generalized concentration addition predicts joint effects of aryl hydrocarbon receptor agonists with partial agonists and competitive antagonists. Environ. Health Perspect. 118, 666-672 (2009).
24. Pandini, A. et al. Detection of the TCDD binding-fingerprint within the Ah receptor ligandbinding domain by structurally drivenmutagenesis and functionalanalysis. Biochemistry 48, 5972-5983 (2009).
25. Opitz, C. A. et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478, 197-203 (2011).
26. Fallarino, F., Grohmann, U. & Puccetti, P. Indoleamine 2,3-dioxygenase: from catalyst to signaling function. Eur. J. Immunol. 42, 1932-1937 (2012).
27. De Luca, A. et al. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J. Immunol. 179, 5999-6008 (2007).
28. Pallotta, M. T. et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nature Immunol. 12, 870-878 (2011).
29. Dong, B. et al. FRET analysis of protein tyrosine kinase c-Src activation mediated via aryl hydrocarbon receptor. Biochim. Biophys. Acta 1810, 427-431 (2011).
30. Randi, A. S. et al. Hexachlorobenzene triggers AhR translocation to the nucleus, c-Src activation and EGFR transactivation in rat liver. Toxicol. Lett. 177, 116-122 (2008).
31. Backlund, M. & Ingelman-Sundberg, M. Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinases. Cell. Signal. 17, 39-48 (2005).
32. Thiennimitr, P. et al. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc. Natl Acad. Sci. USA 108, 17480-17485 (2011).
33. Puliti, M., Uematsu, S., Akira, S., Bistoni, F. & Tissi, L. Toll-like receptor 2deficiency is associated with enhanced severity of groupBstreptococcal disease. Infect. Immun. 77, 1524-1531 (2009).
34. Matzinger, P. & Kamala, T. Tissue-based class control: the other side of tolerance. Nature Rev. Immunol. 11, 221-230 (2011).
35. Sander, L. E. et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207, 1453-1464 (2010).
36. Romani, L. & Puccetti, P. Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol. 14, 183-189 (2006).
37. Belladonna, M. L., Orabona, C., Grohmann, U. & Puccetti, P. TGF-b and kynurenines as the key to infectious tolerance. Trends Mol. Med. 15, 41-49 (2009).
38. Medzhitov, R., Schneider, D. S. & Soares, M. P. Disease tolerance as a defense strategy. Science 335, 936-941 (2012).
39. Volpi, C. et al. High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. Nature Commun. 4, 1852 (2013).
40. Grohmann, U. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nature Immunol. 3, 1097-1101 (2002).
41. Fallarino, F. et al. Modulation of tryptophan catabolismby regulatoryT cells. Nature Immunol. 4, 1206-1212 (2003).
42. Munn, D. H. et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191-1193 (1998).
43. Samstein, R. M., Josefowicz, S. Z., Arvey, A., Treuting, P. M. & Rudensky, A. Y. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150, 29-38 (2012).
44. Zelante, T. et al. Tryptophan catabolites frommicrobiota engage aryl hydrocarbon receptor andbalancemucosal reactivity via interleukin-22. Immunity 39, 372-385 (2013).
45. Zelante, T., Fallarino, F., Bistoni, F., Puccetti, P. & Romani, L. Indoleamine 2,3- dioxygenase in infection: the paradox of an evasive strategy that benefits the host. Microbes Infect. 11, 133-141 (2009).
46. Chen, W. IDO: more than an enzyme. Nature Immunol. 12, 809-811 (2011).
47. Martinon, F., Mayor, A. & Tschopp, J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229-265 (2009).
48. Chambers, M. C. & Schneider, D. S. Balancing resistance and infection tolerance through metabolic means. Proc. Natl Acad. Sci. USA 109, 13886-13887 (2012).